Join the multi-stakeholder steering committee of CT:IQ to be part of the action that will drive this project and help it to achieve success. Together we can improve the efficiency and effectiveness of clinical trials that are patient-centred and integrated into the Australian health care system.
Benefits of Membership
- Participate in the identification and nomination of topics.
- Contribute to discussions and prioritisation of projects.
- Named representative on the Steering Committee who will engage in discussions on strategies to address selected topics. This will include advising the Executive on what format the project will take and advice on techniques for synthesizing, communicating and implementing recommendations once completed.
- Receive regular reports about the progress of projects and collaborations.
- Receive public acknowledgement of participation in and contributions to CT:IQ.
- Collaborate and exchange ideas with stakeholders from multiple sectors about how to improve the clinical trial sector in Australia.
Responsibilities of Members
- Actively participate in activities and discussions.
- Seek opportunities to advance the mission.
- Engage in constructive conversations with a variety of stakeholders with divergent views on issues.
- Promote adoption of recommendations within the clinical trial sector.
- Keep abreast of, and communicate with, parallel initiatives and projects.
The CT:IQ project is receiving funding from MTPConnect for a pilot project which will run until December 2019. In order to progress, there is a requirement for the MTP Connect funds to be matched by other sources. The funding supports CT:IQ infrastructure and provides direct project support.
The fees below are applicable for the duration of this pilot project (i.e. until December 2019); thereafter annual membership fees will be applicable and the rates will be reviewed. If you are unsure as to which category your organisation falls under please do get in touch to discuss further.
In kind contributions are also very welcome and will be acknowledged appropriately, however, these cannot replace financial contributions according to our auditing requirements.
Commercial for-profit entities
Industry advocacy groups
Professional and educational societies, research/academic institutes
Clinical Trials Networks
Patient/disease advocacy groups
Individual patient/caregiver representatives
Commercial for-profit entities – $20,000
Industry advocacy groups – $10,000
Health Services – $10,000
Professional and educational societies, research/academic institutes – $5,000
Clinical Trials Networks – $1,000
Patient/disease advocacy groups – $1,000
Individual patient/caregiver representatives – No fee
Government departments – No fee*